Summit Therapeutics (SMMT) FCF Margin (2020 - 2022)
Summit Therapeutics (SMMT) posted FCF Margin of 3879.55% for Q3 2022, up 53.27% on a QoQ basis from 8302.13% in Q2 2022, and down 207962.0% year-over-year from N/an in Q3 2021.
Summit Therapeutics (SMMT) FCF Margin (2020 - 2022) Analysis & Trends
Summit Therapeutics' FCF Margin history runs 3 years deep, the most recent figure standing at 3879.55% for Q3 2022.
- Quarterly FCF Margin fell 207962.0% year-over-year to 3879.55% in Q3 2022, while the trailing twelve-month figure through Jun 2023 was 20823.18% (down 1731550.0% YoY) and the FY2022 annual result came in at 5986.67%, down 195720.0% from the prior year.
- FCF Margin was 3879.55% for Q3 2022 at Summit Therapeutics, up from 8302.13% in the prior quarter.
- Across five years, FCF Margin topped out at 1539.81% in Q1 2020 and bottomed at 33903.51% in Q2 2021.
- A 3-year average of 8753.47% and a median of 7744.8% in 2022 frame the typical range for FCF Margin.
- Annual changes were most pronounced in 2021 — FCF Margin plunged 2292645 bps — and 2022, when it soared 2560138 bps.
- Summit Therapeutics' FCF Margin stood at 4335.68% in 2020, then advanced by 15 bps to 3704.78% in 2021, then fell by 5 bps to 3879.55% in 2022.
- Business Quant data shows SMMT's FCF Margin at 3879.55% in Q3 2022, 8302.13% in Q2 2022, and 7744.8% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 10.45% |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 43.35% |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 23.53% |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Summit Therapeutics | 10.60 Bn | 10.00 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | -3,879.55% |
| Jun 30, 2022 | -8,302.13% |
| Mar 31, 2022 | -7,744.80% |
| Dec 31, 2021 | -3,704.78% |
| Sep 30, 2021 | -1,799.92% |
| Jun 30, 2021 | -33,903.51% |
| Mar 31, 2021 | -10,785.42% |
| Dec 31, 2020 | -4,335.68% |
| Sep 30, 2020 | -9,315.47% |
| Jun 30, 2020 | -10,977.06% |
| Mar 31, 2020 | -1,539.81% |